Teltexa Beta 25 Tablet ER
Marketer
Neucure Lifesciences Private Limited
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Teltexa Beta 25 Tablet ER
CardioBeta 25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician. Continue treatment as prescribed; high blood pressure often lacks symptoms, so self-discontinuation is dangerous and can worsen your condition. Lifestyle modifications, including exercise, weight management, and a healthy diet, further enhance blood pressure control. Adhere strictly to your doctor's instructions. Potential side effects include headache, weakness, dizziness, low blood pressure, elevated potassium, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor about kidney or liver issues before starting treatment. Pregnant or breastfeeding individuals require physician consultation prior to use. Always disclose all current medications, particularly those for hypertension or heart conditions.
Uses of Teltexa Beta 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Teltexa Beta 25 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Teltexa Beta 25 Tablet ER with a meal.
Common Side effects of Teltexa Beta 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Teltexa Beta 25 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Teltexa Beta 25 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.
How Teltexa Beta 25 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Teltexa Beta 25 ER tablets, provide dual action for blood pressure reduction.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Teltexa Beta 25 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Teltexa Beta 25 tablets pose a confirmed risk to the fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Teltexa Beta 25 tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release Teltexa Beta 25 tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Teltexa Beta 25 Tablet ER without requiring a change in dosage.
LiverCAUTION
Patients with liver impairment should use Teltexa Beta 25 Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended.
What if you forget to take Teltexa Beta 25 Tablet ER :
Should you forget a dose of Teltexa Beta 25 Tablet ER, take it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Teltexa Beta 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Heart |






